| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/14651858.CD006049 |
| P2093 | author name string | Dan H Moore | |
| Robert G Miller | |||
| Valeria Sogos | |||
| Andrea Diana | |||
| Paolo Bongioanni | |||
| P2860 | cites work | Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints | Q27860640 |
| Glutamate levels in cerebrospinal fluid in amyotrophic lateral sclerosis: a reappraisal using a new HPLC method with coulometric detection in a large cohort of patients | Q28215473 | ||
| El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis | Q29619074 | ||
| Excitotoxic and oxidative cross-talk between motor neurons and glia in ALS pathogenesis | Q35617722 | ||
| A summary of mechanistic hypotheses of gabapentin pharmacology | Q41743616 | ||
| Phase III randomized trial of gabapentin in patients with amyotrophic lateral sclerosis | Q43569621 | ||
| Motor unit hyperexcitability in amyotrophic lateral sclerosis vs amino acids acting as neurotransmitters | Q44029869 | ||
| Distribution of GABAAReceptor mRNA in the Motor Cortex of ALS Patients | Q44629514 | ||
| Gabapentin activates presynaptic GABAB heteroreceptors in rat cortical slices | Q44974840 | ||
| Placebo-controlled trial of gabapentin in patients with amyotrophic lateral sclerosis. WALS Study Group. Western Amyotrophic Lateral Sclerosis Study Group | Q46827288 | ||
| CSF and plasma amino acid levels in motor neuron disease: elevation of CSF glutamate in a subset of patients | Q47631709 | ||
| Amino acids acting as transmitters in amyotrophic lateral sclerosis (ALS). | Q48154923 | ||
| Pharmacologic reversal of cortical hyperexcitability in patients with ALS. | Q51422993 | ||
| Abnormal glutamate metabolism in amyotrophic lateral sclerosis. | Q51628220 | ||
| Extramotor involvement in ALS: PET studies with the GABAA ligand [11C]flumazenil | Q57089144 | ||
| Trial of Baclofen in Amyotrophic Lateral Sclerosis | Q66970762 | ||
| Excitatory amino acids in amyotrophic lateral sclerosis: An update | Q68316442 | ||
| An in vitro investigation into conformational aspects of gabapentin | Q77984379 | ||
| P921 | main subject | amyotrophic lateral sclerosis | Q206901 |
| P577 | publication date | 2006-04-19 | |
| P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
| P1476 | title | Gamma aminobutyric acid (GABA) modulators for amyotrophic lateral sclerosis/motor neuron disease |
Search more.